Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from TOT BIOPHARM International Co. Ltd. ( (HK:1875) ).
TOT BIOPHARM International Co. Ltd. has announced a change in the composition of its board committee. Dr. Liu, Weidong, who was previously the chairperson of the Remuneration Committee, has been replaced by Mr. Zhang, Qing, an independent non-executive director, to comply with the Listing Rules of the Hong Kong Stock Exchange. This change is effective from March 21, 2025, and aims to ensure the company meets regulatory requirements, potentially impacting its governance structure and investor confidence.
More about TOT BIOPHARM International Co. Ltd.
YTD Price Performance: 13.41%
Average Trading Volume: 152,560
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$1.61B
See more insights into 1875 stock on TipRanks’ Stock Analysis page.